参考文献/References:
[1] Holdaway IM, Rajasoorya C. Epidemiology of acromegaly [J].
Pituitary, 1999, 2(1): 29-41.
[2] Holdaway IM, Bolland MJ, Gamble GD. A meta-analysis of
the effect of lowering serum levels of GH and IGF-1 on
mortality in acromegaly [J]. Eur J Endocrinol, 2008, 159(2):
89-95.
[3] Dekkers, OM, Biermasz, NR, Pereira AM, et al. Mortality in
acromegaly: a metaanalysis [J]. J Clin Endocrinol Metab,
2008, 93(1):61-67.
[4] Knosp E, Steiner E, Kitz K, et al. Pituitary adenomas with
invasion of the cavernous sinus space: a magnetic resonance
imaging classification compared with surgical findings [J].
Neurosurgery, 1993, 33(4): 610-618.
[5] Wilson CB. Neurosurgical Management of Large and Inva-
sive Pituitary Tumors [M]. Clinical Management of Pituitary
Disorders. New York: Raven Press, 1979. 335-342.
[6] Giustina A, Barkan A, Casanueva FF, et al. Criteria for cure
of acromegaly: a consensus statement [J]. J Clin Endocrinol
Metab, 2000, 85(2): 526-529.
[7] Melmed S, Casanueva FF, Cavagnini, F, et al. Guidelines for
acromegaly management [J]. J Clin Endocrinol Metab, 2002,
87(9): 4054-4058.
[8] Giustina A, Chanson P, Bronstein MD, et al. A consensus on
criteria for cure of acromegaly [J]. J Clin Endocrinol Metab,
2010, 95(7), 3141-3148.
[9] Marquez Y, Tuchman A, Zada G. Surgery and radiosurgery
for acromegaly: a review of indications, operative techni-
ques, outcomes, and complications [J]. Intern J Endocrinol,
2012, 2012: 386401.
[10] Zhao B, Wei YK, Li GL, et al. Extended transsphenoidal
approach for pituitary adenomas invading the anterior
cranial base, cavernous sinus, and clivus: a single-center
experience with 126 consecutive cases [J]. J Neurosurg,
2010, 112(1): 108-117.
[11] Yang, I, Kim, W, De Salles, A, et al. A systematic analysis
of disease control in acromegaly treated with radiosurgery
[J]. Neurosurg Focus, 2010, 29(4): E13.
[12] Shin SS, Tormenti MJ, Paluzzi A, et al. Endoscopic endona-
sal approach for growth hormone secreting pituitary adeno-
mas: outcomes in 53 patients using 2010 consensus criteria
for remission [J]. Pituitary, 2013, 16(4): 435-444.
[13] De P, Rees DA, Davies N, et al. Transsphenoidal surgery for
acromegaly in wales: results based on stringent criteria of
remission [J]. J Clin Endocrinol Metab, 2003, 88(8): 3567-
3572.
[14] Nomikos P, Buchfelder M, Fahlbusch R. The outcome of
surgery in 668 patients with acromegaly using current crite-
ria of biochemical 'cure' [J]. Eur J Endocrinol, 2005, 152
(3): 379-387.
[15] Lüdecke DK. Recent developments in the treatment of
acromegaly [J]. Neurosurg Rev, 1985, 8(3-4): 167-173.
[16] Yamada S, Shishiba Y, Kitano, M, et al. Decrease in human
growth hormone (HGH) levels during transsphenoidal sur-
gery for acromegaly as a guide for prognosis [J]. Endocrinol
Jap, 1985, 32(6): 899-906.
[17] Abe T, Lüdecke DK. Recent primary transnasal surgical
outcomes associated with intraoperative growth hormone
measurement in acromegaly [J]. Clin Endocrinol, 1999, 50
(1), 27-35.
[18] Otani R, Fukuhara N, Ochi T, et al. Rapid growth hormone
measurement during transsphenoidal surgery: analysis of
252 acromegalic patients [J]. Neurol Med Chir (Tokyo),
2012, 52(8), 558-562.
[19] 陈 晓，何新尧，施秀华，等. 生长激素 （GH）水平在垂体
GH腺瘤缓解及预后判断中的意义[J]. 中华神经外科疾
病研究杂志，2013，12（3）：235-238.
[20] Kim EH, Oh MC, Lee EJ, et al. Predicting long-term remis-
sion by measuring immediate postoperative growth hormone
levels and oral glucose tolerance test in acromegaly [J].
Neurosurgery, 2012, 70(5): 1106-1113.
[21] Hazer DB, I??k S, Berker D, et al. Treatment of acromegaly
by endoscopic transsphenoidal surgery: surgical experience
in 214 cases and cure rates according to current consensus
criteria [J]. J Neurosurg, 2013, 119(6), 1467-1477.